PEDIATRICS Vol. 1 No. 4 April 1948, pp. 437-457
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BYERS, R. K.
Right arrow Articles by MOLL, F. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BYERS, R. K.
Right arrow Articles by MOLL, F. C.

ENCEPHALOPATHIES FOLLOWING PROPHYLACTIC PERTUSSIS VACCINE

RANDOLPH K. BYERS M.D.1 and FREDERIC C. MOLL M.D.1

1 The Department of Pediatrics, Harvard Medical School and from the Infants' and Children's Hospitals, Boston, Mass.

Inspection of the records of the Children's Hospital for the past ten years has disclosed 15 instances in which children developed acute cerebral symptoms within a period of hours after the administration of pertussis vaccine. The children varied between 5 and 18 months in age and, in so far as it is possible to judge children of this age range, were developing normally according to histories supplied by their parents. None had had convulsions previously. Many different lots of vaccine, made by eight different manufacturers over a period of eight years, were implicated. The inoculations were given throughout the usual geographic range of children coming to this hospital. All but one, at the time of follow-up or death, showed evidence of impairment of the nervous system, which might still have been in the healing stage in three or four.

During the same period about half as many children were seen in the hospital suffering from the encephalopathy secondary to smallpox vaccination, and about twice as many from the encephalopathy complicating pertussis itself.

A variety of etiologic considerations were suggested by consideration of the reported cases and references to the literature. That constitutional factors may have been involved was suggested by both the preponderance of males as opposed to females, and by the high incidence of abnormalities of the nervous system in the family histories. The clinical course and cytologic abnormalities of spinal fluids found in acute cases indicated an encephalopathy. The literature suggested that this process might have resulted from either the activity of a specific toxin or from an antigen-antibody response. Against the former of these hypotheses was the unstable nature of the heretofore recognized toxins which could hardly survive in properly aged vaccines. The rapid onset of symptoms, occasionally within minutes of the first injection, seemed strong evidence against the second. The present study has left these etiologic considerations unanswered, but it has called attention to a risk of the prophylactic use of pertussis vaccine not hitherto recognized.

In view of the impressive evidence of the effectiveness of prophylactic pertussis vaccine now accumulating, it seems likely that babies are safer vaccinated than not. Further studies should be made to prove this point definitely, for the encephalopathy following pertussis vaccine seems more devastating than the vast majority of the nervous lesions following the use of smallpox vaccine.

Submitted on October 27, 1947




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
S. Mattoo and J. D. Cherry
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
Clin. Microbiol. Rev., April 1, 2005; 18(2): 326 - 382.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. K. Ball, G. Evans, and A. Bostrom
Risky Business: Challenges in Vaccine Risk Communication
Pediatrics, March 1, 1998; 101(3): 453 - 458.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
A. Leviton
Neurologic Sequelae of Pertussis Immunization- 1989
J Child Neurol, October 1, 1989; 4(4): 311 - 314.
[PDF]